| Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 | Cell | 2020 | 1.3K |
| Autoantibodies against type I IFNs in patients with life-threatening COVID-19 | Science | 2020 | 1.1K |
| Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19 | Cell | 2020 | 955 |
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update | Annals of the Rheumatic Diseases | 2020 | 851 |
| Gastric cancer | Lancet, The | 2020 | 607 |
| Guidelines and definitions for research on epithelial-mesenchymal transition | Nature Reviews Molecular Cell Biology | 2020 | 469 |
| Dealing with sleep problems during home confinement due to the COVID-19 outbreak: Practical recommendations from a task force of the European CBT-I Academy | Journal of Sleep Research | 2020 | 401 |
| The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 | Cell | 2020 | 347 |
| European Position Paper on Rhinosinusitis and Nasal Polyps 2020 | Rhinology | 2020 | 308 |
| HPV Vaccination and the Risk of Invasive Cervical Cancer | New England Journal of Medicine | 2020 | 268 |
| Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis | Gastroenterology | 2020 | 234 |
| Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies | JAMA Neurology | 2020 | 200 |
| Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR | Nature Communications | 2020 | 199 |
| Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial | Lancet, The | 2020 | 189 |
| Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science | Cardiovascular Research | 2020 | 184 |
| Natural killer cell immunotypes related to COVID-19 disease severity | Science Immunology | 2020 | 183 |
| 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis | Annals of the Rheumatic Diseases | 2020 | 173 |
| Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database | Genetics in Medicine | 2020 | 164 |
| Potential impact of seasonal forcing on a SARS-CoV-2 pandemic | Swiss Medical Weekly | 2020 | 158 |
| Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria | New England Journal of Medicine | 2020 | 152 |
| An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction | Nature Communications | 2020 | 151 |
| Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure | Circulation | 2020 | 145 |
| Long-term consequences of COVID-19: research needs | Lancet Infectious Diseases, The | 2020 | 137 |
| Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients | EMBO Molecular Medicine | 2020 | 135 |
| Risks to healthcare workers following tracheal intubation of patients with COVID-19: a prospective international multicentre cohort study | Anaesthesia | 2020 | 131 |
